Epigenetic Regulation in Parkinson’s Disease: Cutting -Edge Insights into miRNAs, lncRNAs and Chromatin Modifiers
Current insights into the roles of miRNAs, lncRNAs, and chromatin modifiers in Parkinson’s disease are critically summarized, their potential as biomarkers and therapeutic targets are discussed, and key challenges and future perspectives in translating epigenetic discoveries into clinical applications are highlighted.